Nova IVI Fertility LLC Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02523898
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Director GCC-Operations | Nova IVI Fertility LLC .Royale Marina Office, B22-23 P.O. 60202.Abu Dhabi/UAE | Nova IVI Fertility, New Delhi

Active Ingredients

Drugs in Phase 2 Trials (2)

clomifene (clomid) (1 trial)

sitagliptin (januvia) (2 trials)

Drugs in Other Trials (2)

cyproviron (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperandrogenism (Phase 2)

Polycystic Ovary Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4